Figure 3.
Figure 3. Knockdown of vcyclin and vFLIP in PEL cells. (A) Graph shows the percent of PEL cells remaining viable as determined by FACS analysis for annexin V-FITC 10 days after infection with sh-vcyclin or sh-vFLIP. □ indicates JSC-1 cells; ▦, BC-3; ▩ , BCP-1; and ▨, HBL-6. (B) Light microscopy (magnification 100 ×) of BC-3 cells 10 days after infection with sh-LANA, sh-vcyclin, or sh-vFLIP shows extensive cell loss with vcyclin or vFLIP knockdown. (C) Graph shows percent of BC-3 cells remaining viable as determined by FACS analysis for annexin V-FITC at timepoints after infection with sh-LANA (▦), sh-vcyclin ( ▩ ), or sh-vFLIP (▨)atanMOI of 10 293t IU/cell. Error bars indicate the standard error of the mean.

Knockdown of vcyclin and vFLIP in PEL cells. (A) Graph shows the percent of PEL cells remaining viable as determined by FACS analysis for annexin V-FITC 10 days after infection with sh-vcyclin or sh-vFLIP. □ indicates JSC-1 cells; ▦, BC-3; ▩ , BCP-1; and ▨, HBL-6. (B) Light microscopy (magnification 100 ×) of BC-3 cells 10 days after infection with sh-LANA, sh-vcyclin, or sh-vFLIP shows extensive cell loss with vcyclin or vFLIP knockdown. (C) Graph shows percent of BC-3 cells remaining viable as determined by FACS analysis for annexin V-FITC at timepoints after infection with sh-LANA (▦), sh-vcyclin ( ▩ ), or sh-vFLIP (▨)atanMOI of 10 293t IU/cell. Error bars indicate the standard error of the mean.

Close Modal

or Create an Account

Close Modal
Close Modal